Severe mycobacterium xenopi infection in 2 immuno-competent spouses: demonstration of environmental exposure through a new AFLP approach

B. Ninet, J. Schrenzel, I. Jan, A. M. Béni, J. P. Janssens (Geneva, Switzerland)

Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Session: Pulmonary infections in the immunocompetent and immunocompromised host
Session type: Thematic Poster Session
Number: 2565
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Ninet, J. Schrenzel, I. Jan, A. M. Béni, J. P. Janssens (Geneva, Switzerland). Severe mycobacterium xenopi infection in 2 immuno-competent spouses: demonstration of environmental exposure through a new AFLP approach. Eur Respir J 2007; 30: Suppl. 51, 2565

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

No human transmission of Mycobacterium malmoense in a perfect storm setting
Source: Eur Respir J 2012; 40: 1576-1578
Year: 2012


Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015



Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016


The first case of mycobacterium shimoidei infection in the UK
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Source: Eur Respir J 2009; 34: 926-931
Year: 2009



Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008



Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010

Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010



Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Residential bathroom is a candidate for source of pulmonary mycobacterium avium complex infection
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006

Accidental detection of mycobacterium tuberculosis infection in patients with various respiratory diseases
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008


Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003



Mycobacterium avium complex infection: phenotypes and outcomes
Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017
Year: 2017



Treatment of latent infection with Mycobacterium tuberculosis: update 2010
Source: Eur Respir J 2011; 37: 690-711
Year: 2011